|
|
???tair.name??? >
???browser.page.title.author???
|
"余明隆"???jsp.browse.items-by-author.description???
Showing items 1-25 of 304 (13 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 高雄醫學大學 |
2014 |
Novel quasi-subgenotype D2 of hepatitis B virus identified in Taiwanese aborigines
|
Tran, H;余明隆;戴嘉言;林怡伶;葉明倫;莊萬龍;Abe, K; Tran, H;Yu, ML;Dai, CY;Lin, IL;Yeh, ML;Chuang, WL;Abe, K |
| 高雄醫學大學 |
2014 |
High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients
|
余明隆;戴嘉言;黃釧峰;李佳蓉;葉明倫;葉時孟;郭行道;黃志富;張哲銘;陳鴻鈞;卓夙航;黃尚志;莊萬龍; Yu, ML;Dai, CY;Huang, CF;Lee, JJ;Yeh, ML;Yeh, SM;Kuo, HT;Huang, JF;Chang, JM;Chen, HC;Juo, SH;Hwang, SJ;Chuang, WL;FORMOSA-LIKE, group. |
| 高雄醫學大學 |
2014 |
在造血幹細胞移植中C型肝炎由帶原者傳染之個案
|
蕭惠樺;劉益昌;王慧晶;吳承翰;卓士峰;許瑞峰;蔡慧珍;S.Y.Hsiao;張肇松;林勝豐;劉大智;莊萬龍;余明隆 ; H.-H.Hsiao;Y.-C.Liu;H.-C.Wang;C.-H.Wu;S.-F.Cho;J.-F.Hsu;H.-J.Tsai1;S.Y.Hsiao;C.-S.Chang;S.-F.Lin;T.-C.Liu;W.-L.Chuang;M.-L.Yu |
| 高雄醫學大學 |
2014 |
Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
|
鄭貞英;蔡孟峰;蔡蕙如;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Tsai, MF;Tsai, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF |
| 高雄醫學大學 |
2014 |
T-cell autophagy deficiency increases mortality and suppresses immune responses after sepsis.
|
林志文;羅錦河;許勤;Hsieh, CH;Chang, YF;Hou, BS;高英賢;Lin, CC;余明隆;袁行修;謝雅晶. ; Lin, CW;Lo, S;Hsu, C;Hsieh, CH;Chang, YF;Hou, BS;Kao, YH;Lin, CC;Yu, ML;Yuan, SS;Hsieh, YC. |
| 高雄醫學大學 |
2014 |
Complete Activation of Autophagic Process Attenuates Liver Injury and Improves Survival in Septic Mice
|
林志文;Lo, S;彭道雄;吳秉家;Lee, PH;Chang, YF;郭柏麟;余明隆;袁行修;謝雅晶; Lin, CW;Lo, S;Perng, DS;Wu, DB;Lee, PH;Chang, YF;Kuo, PL;Yu, ML;Yuan, SS;Hsieh, YC. |
| 高雄醫學大學 |
2014 |
Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy.
|
葉明倫;黃釧峰;黃駿逸;劉淑芬;楊華齡;謝明彥;黃志富;戴嘉言;莊萬龍;余明隆; Yeh, ML;Huang, CF;Huang, CI;Liu, SF;Yang, HL;Hsieh, MY;Huang, JF;Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
inosine triphosphate pyrophosphatase 基因變異與慢性C型肝炎2/3基因型治療復發危險
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;ML*, Yu |
| 高雄醫學大學 |
2014 |
Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes
|
林昆德;李美月;馮久哲;Chen, Brian-Ken;余明隆;辛錫璋; Lin, KD;Lee, MY;Feng, CC;Chen, BK;Yu, ML;Shin, SJ |
| 高雄醫學大學 |
2013 |
Host factors determining the efficacy of hepatitis C treatment.
|
莊萬龍;余明隆 ; Chuang, WL;Yu, ML. |
| 高雄醫學大學 |
2013 |
非肝癌癌症C型肝炎患者接受長效型干擾素合併雷巴威靈治療之療效與安全性多中心研究
|
黃釧峰;黃志富;陳武政;葉明倫;黃駿逸;楊正福;莊萬龍;戴嘉言;謝明彥;林子堯;陳信成;余明隆; Huang, Chung-Feng;Huang, Jee-Fu;Chen, Wu-Cheng;Yeh, Ming-Lun;Huang, Ching-I;Yang, Jeng-Fu;Chuang, Wan-Long;Dai, Chia-Yen;Hsieh, Ming-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Yu, Ming-Lung |
| 高雄醫學大學 |
2013 |
亞洲慢性B型肝炎e抗原陽性病患接受干安能治療之鞏固療法:一多中心研究
|
戴嘉言;曾岱宗;Wong, Grace;黃志富;Wong, Vicent;劉俊人;余明隆;莊萬龍;高嘉宏;陳力元;陳定信 ; Dai, Chia-Yen;Tseng, Tai-Chung;Wong, Grace;Huang, Jee-Fu;Wong, Vicent;Liu, Chun-Jen;Yu, Ming-Lung;Chuang, Wan-Long;Kao, Jia-Horng;Chan, Henry;Chen , Ding-Sjinn |
| 高雄醫學大學 |
2013 |
Sustained hcv clearance and increased HBsAg seroclearance in patients with dual chronic hepatitis C and B during post-treatment follow-up.
|
余明隆;李詮謀;Chen, CL;莊萬龍;盧勝男;劉振樺;Wu, SS;廖麗瑛;郭行道;趙有誠;董水義;楊賢馨;高嘉宏;Su, WW;Lin, CL;Yang, HC;陳培哲;陳定信;劉俊人*;Taiwan Liver-Net, Consortium. ; Yu, ML;Lee, CM;Chen, CL;Chuang, WL;Lu, SN;Liu, CH;Wu, SS;Liao, LY;Kuo, HT;Chao, YC;Tung, SY;Yang, SS;Kao, JH;Su, WW;Lin, CL;Yang, HC;Chen, PJ;Chen, DS;Liu, CJ;Taiwan Liver-Net, Consortium. |
| 高雄醫學大學 |
2013 |
The Evolution of HCV treatment in Taiwan
|
黃釧峰;莊萬龍;余明隆; Huang, CF;Chaung, WL;Yu, ML |
| 高雄醫學大學 |
2013 |
無
|
眭致遠;陳顧中;張琬淑;余明隆;梁中玲;卓夙航; Hsi, Edward;Chen, Ku-Chung;Chang, Wan-Shu;Yu, Ming-Lung;Liang, Chung-Ling;Juo, Suh-Hang Hank |
| 高雄醫學大學 |
2012 |
The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy
|
黃志富;余明隆;黃釧峰;卓夙航;戴嘉言;謝明彥;侯乃仁;葉明倫;謝孟軒;楊正福;林子堯;陳信誠;辛鍚章;莊萬龍 ; Huang JF;Yu ML;Huang CF;Juo SH;Dai CY;Hsieh MY;Hou NJ;Yeh ML;Hsieh MH;Yang JF;Lin ZY;Chen SC;Shin SJ;Chuang WL. |
| 高雄醫學大學 |
2012 |
Waist circumference; body mass index; serum uric acid; blood sugar; and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
|
謝孟軒;林文一;潛詡涵;簡麗合;黃兆寬;楊正福;張寧家;黃釧峰;王肈齡;莊萬龍;余明隆;戴嘉言;何啟功 ; Hsieh, MH;Lin, WY;Chien, HH;Chien, LH;Huang, CK;Yang, JF;Chang, NC;Huang, CF;Wang, CL;Chuang, WL;Yu, ML;Dai, CY;Ho, CK |
| 高雄醫學大學 |
2012 |
Raloxifene誘發之肝炎；病例報告
|
林文一;余明隆;李秋慧;楊正福;戴嘉言;張文宇;莊萬龍 |
| 高雄醫學大學 |
2012 |
介白素28B於慢性C型肝炎第一型患者接受24周長效型干擾素合併雷巴威靈縮短療程的角色
|
黃釧峰;黃志富;戴嘉言;莊萬龍;余明隆 |
| 高雄醫學大學 |
2012 |
APRI在預測C型肝炎相關肝纖維化及慢性腎臟病的表現
|
李佳蓉;黃尚志;林明彥;黃釧峰;余明隆;陳鴻鈞 |
| 高雄醫學大學 |
2012 |
Predictors of HCV treatment beyond of IL28B
|
余明隆 |
| 高雄醫學大學 |
2012 |
The impact of thyroid autoantibodies and dysfunction in the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C patients
|
黃志富;戴嘉言;黃釧峰;余明隆;莊萬龍 |
| 高雄醫學大學 |
2012 |
MicroRNA Expression Profiling in Peripheral Blood Mononuclear Cells Identifies Two miRNAs Associated with Treatment Response to Peginterferon-Ribavirin in Chronic Hepatitis C Virus Patients
|
余明隆;眭致遠;黃釧峰;戴嘉言;卓夙航;黃志富;莊萬龍 |
| 高雄醫學大學 |
2012 |
IL28B 基因多性及C型肝炎治療之反應性
|
戴嘉言;黃釧峰;莊萬龍;余明隆 |
Showing items 1-25 of 304 (13 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
